Autophagy in ILC2 is required for disease development in a mouse model of allergic asthma; inhibiting ATG5 in activated ILC2s increases apoptosis due to a deficit in lipophagy and a consequent metabolic shift485. Here, ATG5 is linked to allergic asthma.